Literature DB >> 1370887

Regulation of cytochrome P450 IID by acute phase mediators in C3H/HeJ mice.

C Trautwein1, G Ramadori, G Gerken, K H Meyer zum Büschenfelde, M Manns.   

Abstract

Cytochrome P450 IID6 is a drug metabolizing enzyme and the major target antigen in LKM-1 antibody positive chronic active hepatitis. The histological hallmark of chronic active hepatitis is a lymphocytic infiltrate in the liver. It is unknown whether and how cytokines produced and secreted by these tissue infiltrating mononuclear cells regulate the cellular expression of cytochrome P450 IID6. To study the effect of interleukin 1, tumor necrosis factor and interleukin 6 on the hepatocellular RNA expression of cytochrome P450 IID, we injected each of the cytokines in C3H/HeJ mice. We found a time-dependent suppression of the cytochrome in the liver. Six hours after the intraperitoneal injection of 0.5 micrograms interleukin 1 beta the specific RNA-expression was reduced to 25% of the original level. A similar reduction was found after the injection of 2 micrograms tumor necrosis factor alpha. A mild suppression to 65% of the original level was seen six hours following the dose of 100 ng interleukin 6. Our studies show how immune mediators can change the expression of an autoantigen. Further studies in the human system are necessary to estimate this regulation for the elimination of drugs and in LKM-1 antibody positive chronic active hepatitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370887     DOI: 10.1016/0006-291x(92)91777-n

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Interleukin 6 and liver regeneration.

Authors:  K L Streetz; T Luedde; M P Manns; C Trautwein
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

3.  CREB controls LAP/C/EBP beta transcription.

Authors:  M Niehof; M P Manns; C Trautwein
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

4.  Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null mice.

Authors:  Beatrice A Nyagode; Choon-Myung Lee; Edward T Morgan
Journal:  J Pharmacol Exp Ther       Date:  2010-08-18       Impact factor: 4.030

Review 5.  Pharmacokinetic alterations after severe head injury. Clinical relevance.

Authors:  B A Boucher; S D Hanes
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

6.  Orphan nuclear receptor ERRγ regulates hepatic TGF-β2 expression and fibrogenic response in CCl4-induced acute liver injury.

Authors:  Yong-Hoon Kim; Yoon Seok Jung; Kamalakannan Radhakrishnan; Jina Kim; In-Kyu Lee; Sung Jin Cho; Don-Kyu Kim; Steven Dooley; Chul-Ho Lee; Hueng-Sik Choi
Journal:  Arch Toxicol       Date:  2021-06-30       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.